Challenges in the Classification of High-Grade Neuroendocrine Neoplasms Based on Current Recommendations

被引：0
|
作者：
Joseph, Nancy [1 ]
Kim, Grace [1 ]
Umetsu, Sarah [1 ]
Kakar, Sanjay [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
MODERN PATHOLOGY | 2021年 / 34卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
872
引用
收藏
页码：1046 / 1046
页数：1
相关论文
共 50 条
  • [21] Germline pathogenic variants in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms
    Sorbye, H.
    Venizelos, A.
    Perren, A.
    Couvelard, A.
    Hjortland, G. O.
    Sundlov, A.
    Svensson, J.
    Garresori, H.
    Vestermark, L. W.
    Tabaksblat, E.
    Elvebakken, H.
    Knappskog, S.
    JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 : 35 - 35
  • [22] Role of surgical treatments in high-grade or advanced gastroenteropancreatic neuroendocrine neoplasms
    Que, Qing-Yang
    Zhang, Lin-Cheng
    Bao, Jia-Qi
    Ling, Sun-Bin
    Xu, Xiao
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2022, 14 (05): : 397 - 408
  • [23] Patterns and outcomes of current antitumor therapy for high-grade neuroendocrine neoplasms: perspective of a tertiary referral center
    Melhorn, Philipp
    Spitzer, Julia
    Adel, Thomas
    Wolff, Ladislaia
    Mazal, Peter
    Raderer, Markus
    Kiesewetter, Barbara
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2025, 151 (02)
  • [24] High-grade neuroendocrine neoplasms of the pancreas:A case report and literature review
    He, Zifan
    Zhou, Yang
    Zhou, Feilong
    ASIAN JOURNAL OF SURGERY, 2024, 47 (05) : 2370 - 2372
  • [25] Clinicopathological correlations in 38 cases of gastroenteropancreatic high-grade neuroendocrine neoplasms
    Li, Na
    Hu, Yanping
    Wu, Linguo
    An, Jianduo
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [26] Prognostic Value of Somatostatin Receptor Scintigraphy on High-Grade Neuroendocrine Neoplasms and Impact on the Treatment Decision of Intermediate-Grade Neuroendocrine Neoplasms
    Jia, R.
    Fu, Y. L.
    Lin, L.
    Wang, Y.
    Ge, F. J.
    Zhao, C. H.
    Li, Z. Q.
    Chen, Y. L.
    Liu, L. J.
    Liu, J. Z.
    Xu, J. M.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 236 - 236
  • [27] The Problem of High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms Well-Differentiated Neuroendocrine Tumors, Neuroendocrine Carcinomas, and Beyond
    Sorbye, Halfdan
    Baudin, Eric
    Perren, Aurel
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2018, 47 (03) : 683 - +
  • [28] Impacts of pembrolizumab therapy on immune phenotype in patients with high-grade neuroendocrine neoplasms
    MacFarlane, Alexander W.
    Yeung, Ho-Man
    Alpaugh, R. Katherine
    Dulaimi, Essel
    Engstrom, Paul F.
    Dasari, Arvind
    Campbell, Kerry S.
    Vijayvergia, Namrata
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (07) : 1893 - 1906
  • [29] EpiCO (epirubicin, cyclophosphamide and vincristine) as treatment for extrapulmonary high-grade neuroendocrine neoplasms
    Munker, Stefan
    Vogelhuber, Martin
    Bornschein, Jan
    Stroszczynski, Christian
    Evert, Matthias
    Schlitt, Hans
    Herr, Wolfgang
    Teufel, Andreas
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2020, 58 (02): : 133 - 136
  • [30] PRRT in high-grade gastroenteropancreatic neuroendocrine neoplasms (WHO G3)
    Sorbye, Halfdan
    Kong, Grace
    Grozinsky-Glasberg, Simona
    ENDOCRINE-RELATED CANCER, 2020, 27 (03) : R67 - R77
12345